Moleculin Biotech Inc Stock Prediction and Forecast [MBRX]

AI-generated source summary

The video provides a technical analysis of MBRX stock, traded on NASDAQ. As of December 2, 2025, the analysis assigns a strong sell candidate rating with a score of negative 5, and its current value is at $6.63. The stock is currently at the lower end of a very wide and declining trend. If it breaks below the trend floor of $6.62, then the decrease will be pronounced. The prediction for the trend over the next 3 months varies from -2.95% to +90.31%. Over the next 12 months, the price is projected to drop by 64.65%, where it may vary from complete loss to +17.68%. An initial pivot bottom buy signal was indicated. However, negative signals have developed. Moving averages reveal a negative forecast. The next price is anticipated on December 3 at $6.66 when it is likely to open higher by 3 cents. Accumulation/distribution trading data indicates no support, and the analysis shows weekly volatility is at 7.62% or very high risk.

AI-generated summary based on the source content.

Evidence and evaluation progress

1. Original source published

   03 Dec 2025, 03:58 UTC

   The analyst published the original source item.

2. First prediction resolved

   08 Dec 2025, 14:30 UTC

   The first evaluable outcome in this case reached a terminal result.

3. Case evaluation completed

   08 Dec 2025, 14:30 UTC

   All evaluable predictions in this case reached terminal outcomes.

4. Source recorded by Tahlil Plus

   18 May 2026, 20:23 UTC

   The public source was preserved as the evidence record for this case.

5. Market predictions extracted

   18 May 2026, 20:47 UTC

   1 eligible signal linked to this case.

6. Outcome tracking started

   02 Jul 2026, 02:12 UTC

   Tahlil Plus began monitoring the extracted predictions.